Edition:
United Kingdom

Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

2.92EUR
4:35pm GMT
Change (% chg)

€-0.03 (-1.02%)
Prev Close
€2.95
Open
€2.92
Day's High
€2.95
Day's Low
€2.92
Volume
22,656
Avg. Vol
47,138
52-wk High
€3.46
52-wk Low
€2.56

Chart for

About

Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. These products use viral vectors to directly or indirectly destroy diseased cells. The Company has approximately three products in clinical development: two immunotherapy products for... (more)

Overall

Beta: -0.15
Market Cap(Mil.): €186.79
Shares Outstanding(Mil.): 56.43
Dividend: --
Yield (%): --

Financials

  TRNG.PA Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.50 -- --
ROI: -39.20 0.28 15.02
ROE: -143.68 0.94 16.60

Earnings vs. Estimates